These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

110 related items for PubMed ID: 8856474

  • 1. Tranilast restores cytokine-induced nitric oxide production against platelet-derived growth factor in vascular smooth muscle cells.
    Hishikawa K, Nakaki T, Hirahashi J, Marumo T, Saruta T.
    J Cardiovasc Pharmacol; 1996 Aug; 28(2):200-7. PubMed ID: 8856474
    [Abstract] [Full Text] [Related]

  • 2. Tranilast inhibits the effects of platelet-derived growth factor on cell proliferation and induction of nitric oxide.
    Hishikawa K, Nakaki T, Hirahashi J, Marumo T, Saruta T.
    Eur J Pharmacol; 1995 Nov 30; 291(3):435-8. PubMed ID: 8719431
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Antiproliferative effect of L-NAME on rat vascular smooth muscle cells.
    El Mabrouk M, Singh A, Touyz RM, Schiffrin EL.
    Life Sci; 2000 Aug 18; 67(13):1613-23. PubMed ID: 10983855
    [Abstract] [Full Text] [Related]

  • 5. Inhibitory mechanism of tranilast in human coronary artery smooth muscle cells proliferation, due to blockade of PDGF-BB-receptors.
    Watanabe S, Matsuda A, Suzuki Y, Kondo K, Ikeda Y, Hashimoto H, Umemura K.
    Br J Pharmacol; 2000 May 18; 130(2):307-14. PubMed ID: 10807667
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Inhibitory effects of tranilast on expression of transforming growth factor-beta isoforms and receptors in injured arteries.
    Ward MR, Sasahara T, Agrotis A, Dilley RJ, Jennings GL, Bobik A.
    Atherosclerosis; 1998 Apr 18; 137(2):267-75. PubMed ID: 9622270
    [Abstract] [Full Text] [Related]

  • 8. Platelet-derived growth factor suppresses and fibroblast growth factor enhances cytokine-induced production of nitric oxide by cultured smooth muscle cells. Effects on cell proliferation.
    Scott-Burden T, Schini VB, Elizondo E, Junquero DC, Vanhoutte PM.
    Circ Res; 1992 Nov 18; 71(5):1088-100. PubMed ID: 1327576
    [Abstract] [Full Text] [Related]

  • 9. Blockade of DNA synthesis induced by platelet-derived growth factor by tranilast, an inhibitor of calcium entry, in vascular smooth muscle cells.
    Nie L, Mogami H, Kanzaki M, Shibata H, Kojima I.
    Mol Pharmacol; 1996 Oct 18; 50(4):763-9. PubMed ID: 8863820
    [Abstract] [Full Text] [Related]

  • 10. Tranilast inhibits the growth of rat mesangial cells.
    Ikeda M, Ikeda U, Shimada K, Fujita N, Okada K, Saito T, Minota S, Kano S.
    Eur J Pharmacol; 1997 Apr 18; 324(2-3):283-7. PubMed ID: 9145784
    [Abstract] [Full Text] [Related]

  • 11. The anti-platelet agent, ticlopidine, upregulates interleukin-1-Beta-stimulated nitric oxide production in cultured rat vascular smooth muscle cells.
    Inoue M, Kusano E, Ito C, Akimoto T, Iimura O, Nemoto J, Amemiya M, Muto S, Asano Y.
    Exp Nephrol; 2002 Apr 18; 10(4):267-74. PubMed ID: 12097830
    [Abstract] [Full Text] [Related]

  • 12. Tranilast inhibits vascular smooth muscle cell growth and intimal hyperplasia by induction of p21(waf1/cip1/sdi1) and p53.
    Takahashi A, Taniguchi T, Ishikawa Y, Yokoyama M.
    Circ Res; 1999 Mar 19; 84(5):543-50. PubMed ID: 10082476
    [Abstract] [Full Text] [Related]

  • 13. Tranilast suppresses intimal hyperplasia in the balloon injury model and cuff treatment model in rabbits.
    Fukuyama J, Ichikawa K, Miyazawa K, Hamano S, Shibata N, Ujiie A.
    Jpn J Pharmacol; 1996 Apr 19; 70(4):321-7. PubMed ID: 8774760
    [Abstract] [Full Text] [Related]

  • 14. Inhibition of nitric oxide synthesis in vascular smooth muscle by retinoids.
    Hirokawa K, O'Shaughnessy KM, Ramrakha P, Wilkins MR.
    Br J Pharmacol; 1994 Dec 19; 113(4):1448-54. PubMed ID: 7534188
    [Abstract] [Full Text] [Related]

  • 15. The induction of nitric oxide synthase activity is inhibited by TGF-beta 1, PDGFAB and PDGFBB in vascular smooth muscle cells.
    Schini VB, Durante W, Elizondo E, Scott-Burden T, Junquero DC, Schafer AI, Vanhoutte PM.
    Eur J Pharmacol; 1992 Jun 17; 216(3):379-83. PubMed ID: 1385162
    [Abstract] [Full Text] [Related]

  • 16. Platelets inhibit the induction of nitric oxide synthesis by interleukin-1 beta in vascular smooth muscle cells.
    Durante W, Schini VB, Kroll MH, Catovsky S, Scott-Burden T, White JG, Vanhoutte PM, Schafer AI.
    Blood; 1994 Apr 01; 83(7):1831-8. PubMed ID: 8142651
    [Abstract] [Full Text] [Related]

  • 17. Dual functionality of cyclooxygenase-2 as a regulator of tumor necrosis factor-mediated G1 shortening and nitric oxide-mediated inhibition of vascular smooth muscle cell proliferation.
    Haider A, Lee I, Grabarek J, Darzynkiewicz Z, Ferreri NR.
    Circulation; 2003 Aug 26; 108(8):1015-21. PubMed ID: 12912810
    [Abstract] [Full Text] [Related]

  • 18. Troglitazone upregulates nitric oxide synthesis in vascular smooth muscle cells.
    Hattori Y, Hattori S, Kasai K.
    Hypertension; 1999 Apr 26; 33(4):943-8. PubMed ID: 10205228
    [Abstract] [Full Text] [Related]

  • 19. Tranilast antagonizes angiotensin II and inhibits its biological effects in vascular smooth muscle cells.
    Miyazawa K, Fukuyama J, Misawa K, Hamano S, Ujiie A.
    Atherosclerosis; 1996 Apr 05; 121(2):167-73. PubMed ID: 9125291
    [Abstract] [Full Text] [Related]

  • 20. Blockade of smooth muscle cell migration and proliferation in baboon aortic explants by interleukin-1beta and tumor necrosis factor-alpha is nitric oxide-dependent and nitric oxide-independent.
    Kenagy RD, Clowes AW.
    J Vasc Res; 2000 Apr 05; 37(5):381-9. PubMed ID: 11025401
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.